The stock market is down Monday, with the Dow Jones Industrial Average down 0.20%, the Nasdaq down 0.04% and the S&P 500 down 0.39%. Today’s sole winner is a pharmaceutical company with a kidney drug that passed a trial, and today’s sole loser announced that its yearly profit will fall short of prior estimates.
This is today’s market winner and loser.
Shares of Keryx Biopharmaceuticals Inc. (NASDAQ: KERX) are up 41.40% to $4.85 on trading volume of 10.7 million shares. A kidney disease drug the company is trying to get on the market has passed a late-stage trial. The 52-week high is $5.19.
Shares of Jos. A Bank Clothiers Inc. (NASDAQ: JOSB) are down 16.25% to $38.75 on trading volume of 1.7 million shares. The company announced that 2012 profit will fall 20% compared to the prior year because of warmer-than-usual weather and U.S. political unease. Before Monday, the 52-week low was $39.54.
Follow Samuel on Twitter: SWeigley
Sponsored: Find a Qualified Financial Advisor
Finding a qualified financial advisor doesn’t have to be hard. SmartAsset’s free tool matches you with up to 3 fiduciary financial advisors in your area in 5 minutes. Each advisor has been vetted by SmartAsset and is held to a fiduciary standard to act in your best interests. If you’re ready to be matched with local advisors that can help you achieve your financial goals, get started now.